
One person's trash can be another person's treasure, but should you buy slumping Oklo?
Apenas manchetes de alto sinal - eventos macro, resultados, M&A, regulatório. Listicles e clickbait de analistas filtrados por padrão. Atualizado a cada hora.

One person's trash can be another person's treasure, but should you buy slumping Oklo?
Last week, Oklo announced a $1 billion at-the-market equity offering program, which stoked dilution concerns.
Investors weighed housing weakness, potential equity dilution, and softer U.S. consumer demand.

NuScale Power stock spiked in value despite minimal news.
The prior program raised $1 billion on 17.97 million shares

Oklo shares sink on plans of raising $1 billion in fresh capital. Here’s why the announcement is largely bearish for OKLO stock.

Despite the sale, the CEO retains extensive direct and indirect holdings.

Oklo Inc (NYSE:OKLO) shares fell more than 7% on Friday after the company launched a new $1 billion at-the-market stock offering program. The move follows the full utilization of Oklo's previous $1 billion ATM program, which was launched in May and exhausted within four months. Under that...

Oklo Inc. (NYSE:OKLO) shares fell 3.

UBS just slapped a Sell rating on NuScale Power and slashed its price target, citing a bear case built around a timeline the market had not fully priced in. Whether the company's unique regulatory standing and cash cushion are enough to hold the thesis together is the question investors are now scrambling to answer.
OKLO established the at-the-market program a day after terminating its previous facility, under which it sold nearly 17.97 million shares for about $1 billion in gross proceeds.

Oklo's reactors are a seemingly perfect solution for AI's power needs.

Piper Sandler just split the advanced nuclear sector down the middle with opposing calls, and the market responded by punishing every name in the group equally, even the one that got a Buy.

OKLO's ambitious nuclear buildout faces a pivotal stretch as investors weigh timelines, spending needs and execution challenges.
One nuclear stock wins praise while another faces brutal downside
Piper Sandler initiated coverage of Oklo with an ‘Overweight’ rating and a $55 price target, implying an upside of about 29%.

The microreactor maker won't attract too many risk-seeking investors in this choppy market.

Nuclear investors should weigh growth potential against a company's valuation.

Stocks took a beating Tuesday as surging oil prices and looming inflation data rattled every corner of the market, and now Wall Street analysts are reshuffling their calls on names ranging from nuclear energy upstart Oklo to retail giants Abercrombie and Ulta Beauty.

Despite its tumble this year, analysts see a brighter future for Oklo than for NuScale.
NuScale Power’s stock saw its prices climb most since April.

Holtec Nuclear is seeking to raise about $900 million as it prepares to restart the Palisades nuclear plant and expand into small modular reactors.

Small modular reactor stocks are surging against a red broad market, but with NuScale and Oklo still deep in the red for the year, the real question is whether this is a genuine bottom or just another bounce trap in a brutal downtrend.
Shay Boloor, chief market strategist at Futrum Equities, said in a post on X that a bigger opportunity for the company lies in its fuel cycle.

Oklo doesn't generate meaningful revenue, so an investment today is a bet on its future.

Two SMR stocks have wildly different valuations.

Choosing an SMR stock depends on how AI companies choose to adopt nuclear energy.
We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.